prednisolone has been researched along with Cryptogenic Fibrosing Alveolitis in 11 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Excerpt | Relevance | Reference |
|---|---|---|
| "It has been reported that cyclosporine A (CYA) treatment may benefit idiopathic pulmonary fibrosis (IPF) patients." | 9.20 | Cyclosporine A combined with low-dose corticosteroid treatment in patients with idiopathic pulmonary fibrosis. ( Azuma, A; Inase, N; Inoue, E; Kudoh, S; Miyazaki, Y; Ogura, T; Sugiyama, Y; Takeuchi, M; Taniguchi, H; Yoshizawa, Y, 2015) |
| "It has been reported that cyclosporine A (CYA) treatment may benefit idiopathic pulmonary fibrosis (IPF) patients." | 5.20 | Cyclosporine A combined with low-dose corticosteroid treatment in patients with idiopathic pulmonary fibrosis. ( Azuma, A; Inase, N; Inoue, E; Kudoh, S; Miyazaki, Y; Ogura, T; Sugiyama, Y; Takeuchi, M; Taniguchi, H; Yoshizawa, Y, 2015) |
| " According to the possibility of either idiopathic pulmonary fibrosis or chronic hypersensitivity pneumonitis, treatment included prednisolone, azathioprine, acetylcysteine and avoidance of contact with the parakeet, but there was an unfavorable response and the patient was subsequently referred for lung transplant." | 3.79 | Clinical case: Differential diagnosis of idiopathic pulmonary fibrosis. ( Alfaro, TM; Cordeiro, CR; Freitas, S, 2013) |
| "Ten years later, the usual interstitial pneumonia (UIP) pattern appeared on chest computed tomography (CT)." | 1.48 | Usual interstitial pneumonia following resolution of cavitated pulmonary masses in a patient with ANCA-associated vasculitis. ( Fukui, S; Hishima, T; Kamei, S; Kobayashi, S; Setoguchi, K; Takizawa, Y, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 8 (72.73) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Singh, P | 1 |
| Behera, D | 1 |
| Gupta, S | 1 |
| Deep, A | 1 |
| Priyadarshini, S | 1 |
| Padhan, P | 1 |
| Cordeiro, CR | 1 |
| Alfaro, TM | 1 |
| Freitas, S | 1 |
| Fukui, S | 1 |
| Kobayashi, S | 1 |
| Kamei, S | 1 |
| Takizawa, Y | 1 |
| Setoguchi, K | 1 |
| Hishima, T | 1 |
| Ohkubo, H | 1 |
| Kunii, E | 1 |
| Moriyama, S | 1 |
| Niimi, A | 1 |
| Okamoto, T | 1 |
| Fujii, M | 1 |
| Furusawa, H | 1 |
| Tsuchiya, K | 1 |
| Miyazaki, Y | 2 |
| Inase, N | 2 |
| Azuma, A | 1 |
| Taniguchi, H | 1 |
| Ogura, T | 1 |
| Inoue, E | 1 |
| Takeuchi, M | 1 |
| Yoshizawa, Y | 1 |
| Sugiyama, Y | 1 |
| Kudoh, S | 1 |
| Takeda, A | 1 |
| Enomoto, T | 1 |
| Sanuki, N | 1 |
| Nakajima, T | 1 |
| Takeda, T | 1 |
| Sayama, K | 1 |
| Kunieda, E | 1 |
| Gribbin, J | 1 |
| Hubbard, R | 1 |
| Smith, C | 1 |
| Behr, J | 2 |
| Costabel, U | 2 |
| Worth, H | 1 |
| McGrath, EE | 1 |
| Millar, AB | 1 |
| Wells, AU | 1 |
| Cottin, V | 1 |
| Poletti, V | 1 |
2 trials available for prednisolone and Cryptogenic Fibrosing Alveolitis
| Article | Year |
|---|---|
Cyclosporine A combined with low-dose corticosteroid treatment in patients with idiopathic pulmonary fibrosis.
Topics: Aged; Cyclosporine; Female; Glucocorticoids; Humans; Idiopathic Pulmonary Fibrosis; Immunosuppressiv | 2015 |
[Comments of the DGP on the press release dated 21.10. 2011 of the National Heart, Lung and Blood Institute about the PANTHER Study on IPF patients].
Topics: Acetylcysteine; Aged; Aged, 80 and over; Azathioprine; Drug Therapy, Combination; Evidence-Based Med | 2011 |
9 other studies available for prednisolone and Cryptogenic Fibrosing Alveolitis
| Article | Year |
|---|---|
Nintedanib vs pirfenidone in the management of COVID-19 lung fibrosis: A single-centre study.
Topics: Adult; C-Reactive Protein; COVID-19 Drug Treatment; Ferritins; Humans; Idiopathic Pulmonary Fibrosis | 2022 |
Clinical case: Differential diagnosis of idiopathic pulmonary fibrosis.
Topics: Acetylcysteine; Alveolitis, Extrinsic Allergic; Azathioprine; Diagnosis, Differential; Disease Manag | 2013 |
Usual interstitial pneumonia following resolution of cavitated pulmonary masses in a patient with ANCA-associated vasculitis.
Topics: Aged; Cyclophosphamide; Female; Glucocorticoids; Granulomatosis with Polyangiitis; Humans; Idiopathi | 2018 |
Efficacy of combined corticosteroid and pirfenidone for acute exacerbation of idiopathic pulmonary fibrosis after surgery for lung cancer: a case report.
Topics: Acute-Phase Reaction; Aged, 80 and over; Disease Progression; Drug Therapy, Combination; Glucocortic | 2015 |
The usefulness of KL-6 and SP-D for the diagnosis and management of chronic hypersensitivity pneumonitis.
Topics: Adult; Aged; Alveolitis, Extrinsic Allergic; Anti-Inflammatory Agents; Biomarkers; Chronic Disease; | 2015 |
Acute exacerbation of subclinical idiopathic pulmonary fibrosis triggered by hypofractionated stereotactic body radiotherapy in a patient with primary lung cancer and slightly focal honeycombing.
Topics: Aged; Glucocorticoids; Humans; Idiopathic Pulmonary Fibrosis; Lung Neoplasms; Male; Prednisolone; Ra | 2008 |
Role of diabetes mellitus and gastro-oesophageal reflux in the aetiology of idiopathic pulmonary fibrosis.
Topics: Adult; Aged; Aged, 80 and over; Allopurinol; Antacids; Anti-Inflammatory Agents; Diabetes Complicati | 2009 |
Hot off the breath: triple therapy for idiopathic pulmonary fibrosis--hear the PANTHER roar.
Topics: Acetylcysteine; Aged; Aged, 80 and over; Azathioprine; Drug Therapy, Combination; Evidence-Based Med | 2012 |
Triple therapy in idiopathic pulmonary fibrosis: an alarming press release.
Topics: Acetylcysteine; Azathioprine; Drug Therapy, Combination; Expectorants; Glucocorticoids; Humans; Idio | 2012 |